RSC Advances
Paper
10.3 Hz, 3JHH 6.8 Hz, 2CH2), 5.52 (d, 1H, 2JPH 7.9 Hz, NHAn), 5.80
m-{1,4-[(PhO)2P(O)NHC6H4OP(O)(OPh)2]}[SnPh3Cl]2 (C2OPh).
Mp: 72 ꢀC. Anal. calc. for C66H55Cl2NO7P2Sn2: C, 58.96; H, 4.12;
N, 1.04; found: C, 59.20; H, 4.50; N, 1.35%. Selected IR data
3
(d, 1H, JPH 8.9 Hz, NHAn), 6.94–7.30 (m, 24H, C6H4 + 2Oph +
2An), 7.46–7.49 (m, 18H, 2Ph3Sn), 7.66–7.70 (12H, 2o-Ph3Sn). 31
P
NMR (CDCl3, ppm): d ¼ 3.71, 3.94. 119Sn NMR (CDCl3, ppm):
d ¼ ꢁ47.7.
1
(KBr, cmꢁ1): 3176w (nNH), 1275m (nP]O), 1185s, 967s (nP–N). H
NMR (CDCl3, ppm): d ¼ 6.48 (d, 1H, 2JPH 10.0 Hz, NH), 7.06–7.39
(m, 24H, C6H4 + 4OPh), 7.47–7.49 (m, 18H, 2Ph3Sn), 7.67–7.71
(m, 12H, 2o-Ph3Sn). 31P NMR (CDCl3, ppm): d ¼ ꢁ7.29 (PP–NH),
ꢁ17.26 (PP–O). 119Sn NMR (CDCl3, ppm): d ¼ ꢁ48.2.
m-{1,3-[(Ph)2P(O)NHCH2]2C6H4}[SnPh3Cl]2 (C5Ph). Mp: 118–
120 ꢀC. Anal. calc. for C68H60Cl2N2O2P2Sn2: C, 62.47; H, 4.63; N,
2.14; found: C, 61.99; H, 4.83; N, 2.35%. Selected IR data (KBr,
cmꢁ1): 3341m (nNH), 1132s (nP]O), 996s (nP–N). 1H NMR (CDCl3,
ppm): d ¼ 3.11 (ps-q, 2H, 3JPH 5.8 Hz, NH), 3.96 (ps-t, 4H, 3JPH 7.6
Hz, CH2), 7.19–7.27 (m, 4H, C6H4), 7.41–7.49 (m, 30H, 4Ph +
Ph3Sn), 7.75–7.87 (m, 20H, 4Ph + Ph3Sn). 31P NMR (CDCl3,
ppm): d ¼ 24.55. 119Sn NMR (CDCl3, ppm): d ¼ ꢁ80.8.
m-{1,4-[(Ph)2P(O)N]2C4H8}[SnPh3Cl]2 (C6Ph). Mp: 243 ꢀC.
Anal. calc. for C64H58Cl2N2O2P2Sn2: C, 61.13; H, 4.65; N, 2.23;
found: C, 61.40; H, 4.95; N, 2.32%. Selected IR data (KBr, cmꢁ1):
1127s (nP]O), 963m (nP–N). 1H NMR (MeOD, ppm): d ¼ 3.10 (m,
8H, C4H8), 7.50–7.57 (m, 12H, 4Ph), 7.80–7.91 (m, 8H, 4Ph),
7.44–7.51 (m, 18H, Ph3Sn), 7.67–7.70 (m, 12H, o-Ph3Sn). 31P
NMR (MeOD, ppm): d ¼ 31.80. 119Sn NMR (MeOD, ppm):
d ¼ ꢁ180.7.
m-{1,4-[(Ph)2P(O)NHC6H4OP(O)(Ph)2]}[SnPh3Cl]2 (C2Ph). Mp:
168 ꢀC. Anal. calc. for C66H55Cl2NO3P2Sn2: C, 61.91; H, 4.33; N,
1.09; found: C, 61.30; H, 4.85; N, 1.25%. Selected IR data (KBr,
1
cmꢁ1): 3369w (nNH), 1177s (nP]O), 938s (nP–N). H NMR (CDCl3,
ppm): d ¼ 5.30 (d, 1H, 2JPH 9.1 Hz, NH), 6.82 (d, 2H, 3JHH 8.9 Hz,
C6H4), 6.93 (d, 2H, 3JHH 8.8 Hz, C6H4), 7.40–7.52 (m, 31H, 4Ph +
Ph3Sn), 7.67–7.70 (m, 10H, 4Ph + Ph3Sn), 7.77–7.84 (m, 9H, 4Ph
+ Ph3Sn). 31P NMR (CDCl3, ppm): d ¼ 28.10 (PP–O), 16.33 (PP–NH).
119Sn NMR (CDCl3, ppm): d ¼ ꢁ50.8.
m-{1,4-[(PhO)2P(O)NH]2C6H4}[SnPh3Cl]2 (C3OPh). Mp: 98 ꢀC.
Anal. calc. for C66H56Cl2N2O6P2Sn2: C, 59.01; H, 4.20; N, 2.09;
found: C, 59.19; H, 4.76; N, 1.85%. Selected IR data (KBr, cmꢁ1):
1
3247m (nNH), 1251s (nP]O), 1190s, 948s (nP–N), 1015w. H NMR
3
(CDCl3, ppm): d ¼ 5.4 (d, 2H, JHH 8.8 Hz, 2NH), 7.10 (s, 4H,
C6H4), 7.19–7.32 (m, 20H, 4Oph), 7.46–7.49 (m, 18H, 2Ph3Sn),
7.66–7.69 (12H, 2o-Ph3Sn). 31P NMR (CDCl3, ppm): d ¼ ꢁ7.41.
119Sn NMR (CDCl3, ppm): d ¼ ꢁ49.2.
Crystal structure determination
X-ray crystallography for 6Ph, C2Ph, C4NOPh and C6Ph. X-ray
intensities of ligand 6Ph and complexes C2Ph, C4NOPh and C6Ph
were collected on a Bruker SMART APEXII CCD diffractometer
m-{1,4-[(PhO)2P(O)NHCH2]2C6H4}[SnPh3Cl]2 (C4OPh). Mp:
98 ꢀC. Anal. calc. for C68H60Cl2N2O6P2Sn2: C, 59.55; H, 4.41; N,
2.04; found: C, 59.01; H, 4.80; N, 1.90%. Selected IR data (KBr,
˚
with graphite-monochromatized MoKa radiation (l ¼ 0.71073 A).
1
cmꢁ1): 3351w (nNH), 1238s (nP]O), 1188s, 922s, 953s (nP–N). H
Cell renement and data reduction were performed with the help
of the programs APEX2 (ref. 29) and SAINT.29 The structures were
solved and rened with SHELXTL (5.1)30 by full-matrix least-
squares on F2. All non-hydrogen atoms were rened anisotropi-
cally. Ligand 6Ph was already solved at room temperature,31 but
lacked an absorption correction. Our determination (T ¼ 100 K,
with absorption correction) furnishes more details; so we report
it anyway. C4NOPh is a superposition structure. Indeed, the
Ph3ClSn moieties are related by an inversion, but the ligand
which – according to the synthesis – is achiral may adopt one of
two orientations in different cells. No SRO is expected for this
NMR (CDCl3, ppm): d ¼ 3.33 (m, 2H, 2NH), 4.24 (dd, 4H, 2JPH 9.7
3
3
Hz, JHH 6.9 Hz, 2CH2), 7.12 (s, 4H, C6H4), 7.17 (t, 4H, JHH 7.2
Hz, p-OPh), 7.24 (d, 8H, 3JHH 7.7 Hz, o-OPh), 7.32 (t, 8H, 3JHH 7.8
Hz, m-OPh). 31P NMR (CDCl3, ppm): d ¼ ꢁ1.51. 119Sn NMR
(CDCl3, ppm): d ¼ ꢁ48.0.
m-{1,4-[(PhO)(PhNH)P(O)NHCH2]2C6H4}[SnPh3Cl]2 (C4NOPh).
Mp: 152 ꢀC. Anal. calc. for C68H62Cl2N4O4P2Sn2: C, 59.64; H,
4.56; N, 4.09; found: C, 59.07; H, 4.62; N, 3.90%. Selected IR data
(KBr, cmꢁ1): 3362m, 3277m (nNH), 1197s (nP]O), 946s (nP–N). 1H
2
3
NMR (CDCl3, ppm): d ¼ 3.37 (dt, 2H, JPH 18 Hz, JHH 10.8 Hz,
NHX), 4.05 (m, 4H, 2CH2), 5.84 (d, 2H, 8.5 Hz, NHAn), 6.95–7.28
(m, 24H, C6H4 + 2OPh + 2An), 7.44–7.51 (m, 18H, Ph3Sn), 7.67–
7.73 (m, 12H, o-Ph3Sn). 31P NMR (CDCl3, ppm): d ¼ 3.99. 119Sn
NMR (CDCl3, ppm): d ¼ ꢁ44.2.
ꢀ
phenomenon. Therefore, the space group P2c is a very good
description even with only one ligand. Indeed, all the atoms, but
the O and N atoms of the OPh and NPh moieties overlap so
closely that a desymmetrization was unstable. Furthermore, the
U
jk tensors are big enough to encompass the positions of both,
m-{1,3-[(PhO)2P(O)NHCH2]2C6H4}[SnPh3Cl]2 (C5OPh). Mp:
96 ꢀC. Anal. calc. for C68H60Cl2N2O6P2Sn2: C, 59.55; H, 4.41; N,
2.04; found: C, 59.70; H, 4.52; N, 1.92%. Selected IR data (KBr,
cmꢁ1): 3343w, 3305w (nNH), 1235s (nP]O), 1186s, 951s (nP–N). 1H
NMR (CDCl3, ppm): d ¼ 3.17 (dt, 2H, 2JPH 12.3 Hz, 3JHH 7.1 Hz,
the O and N atoms, which also explains the borderline P–O and
P–N distances. Finally, this also means that the analysis of the
interactions is still valid, except that in certain cells some
interactions are active and others in different cells.
X-ray crystallography for C1OPh and C5OPh. Bragg-intensities
of C1OPh and C5OPh were collected on a Stoe IPDS II diffrac-
3
3
2NH), 4.18 (dd, 4H, JPH 9.8 Hz, JHH 6.9 Hz, 2CH2), 7.11–7.36
(m, 24H, C6H4 + 4OPh), 7.44–7.51 (m, 18H, Ph3Sn), 7.67–7.70
(m, 12H, o-Ph3Sn). 31P NMR (CDCl3, ppm): d ¼ ꢁ1.49.
˚
tometer with graphite-monochromatized MoKa (l ¼ 0.71073 A)
radiation. Cell renement, data reduction and a numerical
absorption correction were performed with the help of the
programs X-AREA (1.62)31 and XRED32 (1.31).32 The structure of
C3OPh was solved with direct methods using the program SIR
2004 (ref. 33) and that of C5OPh with Patterson methods using
the program DIRDIF-2008.34 The structure renement on F2 was
m-{1,3-[(PhO)(PhNH)P(O)NHCH2]2C6H4}[SnPh3Cl]2 (C5NOPh).
Mp: 142–146 ꢀC. Anal. calc. for C68H62Cl2N4O4P2Sn2: C, 59.64; H,
4.56; N, 4.09; found: C, 59.00; H, 4.60; N, 4.25%. Selected IR data
(KBr, cmꢁ1): 3366m, 3289m (nNH), 1201s (nP]O), 940m (nP–N). 1H
3
NMR (CDCl3, ppm): d ¼ 3.28 (m, 2H, 2NHX), 4.07 (dd, 4H, JPH
17490 | RSC Adv., 2015, 5, 17482–17492
This journal is © The Royal Society of Chemistry 2015